Application of a rotating bioreactor consisting of low-cost and ready-to-use medical disposables for in vitro evaluation of the endothelialization efficiency of small-caliber vascular prostheses

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 101 B, Issue 6, 2013, Pages 1061-1068

  Avci Adali, Meltem ^a   Kobba, Joseph ^a   Neumann, Bernd ^a   Lescan, Mario ^a   Perle, Nadja ^a   Wilhelm, Nadja ^a   Wiedmaier, Hartmut ^a   Schlensak, Christian ^a   Wendel, Hans Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

endothelial cell seeding; endothelialization; hemocompatibility; rotating bioreactor; vascular prostheses

Indexed keywords

ACETOXYMETHYL ESTERS; ARTIFICIAL VASCULAR PROSTHESIS; CARDIOVASCULAR INTERVENTION; ENDOTHELIAL CELL SEEDING; ENDOTHELIALIZATION; HEMOCOMPATIBILITY; UNIFORM DISTRIBUTION; VASCULAR PROSTHESIS;

ADHESION; BIOREACTORS; BLOOD VESSEL PROSTHESES; COATINGS; EFFICIENCY; ENDOTHELIAL CELLS; ROTATION; SCANNING ELECTRON MICROSCOPY;

BIOCONVERSION;

CALCEIN; CALCEIN ACETOXYMETHYL ESTER; CHITOSAN; HEPARIN; UNCLASSIFIED DRUG;

ADHERENT CELL; ARTICLE; BARE METAL STENT; BIOREACTOR; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CELL VIABILITY; ENDOTHELIUM; ENDOTHELIUM CELL; GRAFT PATENCY; HUMAN; HUMAN CELL; MATERIAL COATING; SCANNING ELECTRON MICROSCOPY; THROMBOSIS; VASCULAR STENT;

ENDOTHELIAL CELL SEEDING; ENDOTHELIALIZATION; HEMOCOMPATIBILITY; ROTATING BIOREACTOR; VASCULAR PROSTHESES;

BIOCOMPATIBLE MATERIALS; BIOREACTORS; BLOOD VESSEL PROSTHESIS; CELL SURVIVAL; CELLS, CULTURED; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; EQUIPMENT DESIGN; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; POLYTETRAFLUOROETHYLENE; ROTATION;

EID: 84880507958     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32916     Document Type: Article

References (26)

1. Mensah GA, Brown DW,. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 2007; 26: 38-48.
2. Cene CW, Cooper LA,. Death toll from uncontrolled blood pressure in ethnic populations: Universal access and quality improvement may not be enough. Ann Fam Med 2008; 6: 486-489.
3. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S,. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
4. Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P,. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: An analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus Stent Evaluated at Rotterdam Cardiology Hospital) Registries. J Invasive Cardiol 2011; 23: 336-341.
5. Jimenez-Valero S, Moreno R, Sanchez-Recalde A,. Very late drug-eluting stent thrombosis related to incomplete stent endothelialization: In-vivo demonstration by optical coherence tomography. J Invasive Cardiol 2009; 21: 488-490.
6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
7. Heublein B, Ozbek C, Pethig K,. Silicon carbide-coated stents: Clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg 1998; 5: 32-36.
8. Antoniucci D, Bartorelli A, Valenti R, Montorsi P, Santoro GM, Fabbiocchi F, Bolognese L, Loaldi A, Trapani M, Trabattoni D, Moschi G, Galli S,. Clinical and angiographic outcome after coronary arterial stenting with the carbostent. Am J Cardiol 2000; 85: 821-825.
9. Harding SA, Walters DL, Palacios IF, Oesterle SN,. Adjunctive pharmacotherapy for coronary stenting. Curr Opin Cardiol 2001; 16: 293-299.
10. Vrolix MC, Legrand VM, Reiber JH, Grollier G, Schalij MJ, Brunel P, Martinez-Elbal L, Gomez-Recio M, Bär FW, Bertrand ME, Colombo A, Brachman J,. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol 2000; 86: 385-389.
11. Verheye S, Markou CP, Salame MY, Wan B, King SB III, Robinson KA, Chronos NA, Hanson SR,. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000; 20: 1168-1172.
12. Lahann J, Klee D, Pluester W, Hoecker H,. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Biomaterials 2001; 22: 817-826.
13. Jabara R, Chronos N, Robinson K,. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating. Catheter Cardiovasc Interv 2008; 72: 186-194.
14. Kushwaha M, Anderson JM, Bosworth CA, Andukuri A, Minor WP, Lancaster JR Jr, Anderson PG, Brott BC, Jun HW,. A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials 2010; 31: 1502-1508.
15. Burkel WE,. The challenge of small diameter vascular grafts. Med Prog Technol 1988; 14: 165-175.
16. Dermenoudis S, Missirlis Y,. Design of a novel rotating wall bioreactor for the in vitro simulation of the mechanical environment of the endothelial function. J Biomech 2010; 43: 1426-1431.
17. Mall JW, Philipp AW, Rademacher A, Paulitschke M, Buttemeyer R,. Re-endothelialization of punctured ePTFE graft: An in vitro study under pulsed perfusion conditions. Nephrol Dial Transplant 2004; 19: 61-67.
18. Roh JD, Nelson GN, Udelsman BV, Brennan MP, Lockhart B, Fong PM, Lopez-Soler RI, Saltzman WM, Breuer CK,. Centrifugal seeding increases seeding efficiency and cellular distribution of bone marrow stromal cells in porous biodegradable scaffolds. Tissue Eng 2007; 13: 2743-2749.
19. Vinard E, Leseche G, Andreassian B, Costagliola D,. In vitro endothelialization of PTFE vascular grafts: A comparison of various substrates, cell densities, and incubation times. Ann Vasc Surg 1999; 13: 141-150.
20. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, Painter C, Mirensky T, Erickson B, Shinoka T, Breuer CK,. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev 2010; 16: 341-350.
21. Hsu SH, Tsai IJ, Lin DJ, Chen DC,. The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts. Med Eng Phys 2005; 27: 267-272.
22. Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR, Sutherland FW, Perry T, Ochoa E, Thompson CA, Mayer JE Jr, Oesterle SN, Vacanti JP,. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng 2003; 9: 291-299.
23. De, Scheerder I, Wang K, Wilczek K, Meuleman D, Van AR, Vogel G, Piessens J, Van de Werf F., Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 1997; 95: 1549-1553.
24. Hårdhammar PA, van Beusekom HM, Emanuelsson HU, Hofma SH, Albertsson PA, Verdouw PD, Boersma E, Serruys PW, van der Giessen WJ,. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996; 93: 423-430.
25. Begovac PC, Thomson RC, Fisher JL, Hughson A, Gallhagen A,. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003; 25: 432-437.
26. Garner B, Georgevich A, Hodgson AJ, Liu L, Wallace GG,. Polypyrrole-heparin composites as stimulus-responsive substrates for endothelial cell growth. J Biomed Mater Res 1999; 44: 121-129.